On March 27, 2019, IAVI and partners launched the clinical trial of a new HIV vaccine candidate. The clinical trial named IAVI W001 is at the first step in testing the experimental vaccine in humans (Phase I) and will enroll 60 healthy […]
One of the things I like most about working at IAVI is that we are not only focused on research to translate scientific discoveries into affordable, globally accessible public health solutions. We are also passionate about building a critical mass of African […]
The World Health Organisation defines universal health coverage (UHC) as a healthcare system that ensures all people can use quality services that improve their health without putting them at risk of financial harm. Countries cannot expect to achieve that without […]